Assessing mobility and fall risks in older adults with mild cognitive impairment
Multimodal and Longitudinal Assessment of MOBility Disorders in Patients With Mild COGnitive Disorders
This study is trying to find out what factors can help predict falls in older adults with mild cognitive impairment so that better prevention strategies can be developed.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 417 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 2 sites (Lille and 1 other locations) |
| Trial ID | NCT05273125 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on older adults diagnosed with mild cognitive impairment (MCI) to identify specific predictors for falls. It aims to assess gait disorders and the risk of falls in this vulnerable population, as both cognitive and physical impairments can significantly impact their independence. By understanding these predictive factors, the study seeks to inform personalized prevention strategies to mitigate the risk of falls and subsequent cognitive decline. Participants must be able to walk a short distance and comprehend French for neuropsychological assessments.
Who should consider this trial
Good fit: Ideal candidates are older adults over 65 years diagnosed with mild cognitive impairment who can walk 4 meters with or without assistance.
Not a fit: Patients with severe visual or hearing impairments, or those with severe pathologies that hinder follow-up, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved fall prevention strategies for older adults with mild cognitive impairment, enhancing their quality of life and independence.
How similar studies have performed: While there have been studies assessing fall risks in older adults, this specific focus on mild cognitive impairment and its predictive factors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient being diagnosed with MCI, according to the 2011 criteria * Able to walk 4 meters with or without technical assistance * Comprehension of French language allowing the realization of the neuropsychological assessment Exclusion Criteria: * Severe visual or hearing impairment that does not allow the assessment * Severe pathology that makes follow-up impossible * Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of social security insurance, refusal to sign consent form * Under legal protection (guardianship, curatorship, safeguard of justice)
Where this trial is running
Lille and 1 other locations
- Les Bateliers Chu Lille — Lille, France (Recruiting)
- Hop Salengro - Hopital B — Lille, France (Recruiting)
Study contacts
- Principal investigator: Yaohua CHEN, MD — University Hospital, Lille
- Study coordinator: Yaohua CHEN, MD
- Email: Yaohua.chen@chru-lille.fr
- Phone: 0320445962
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.